Manorama Industries Limited (MANORAMA) Q1 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

Cofacto Research Updated August 12, 2026 4 min read

Manorama Industries is a global leader in specialty fats and oils, serving major confectionery and cosmetic brands through a unique, sustainable supply chain of forest-based seeds. Investors are looking to this quarter's results to gauge how the company's expanded capacity and recent capital raise are translating into revenue growth, alongside the impact of recent customs duty changes on margins.

Quick Details
Results dateAugust 13, 2026
QuarterQ1 FY 2026-2027
Previous quarter revenueRs. 382.30 Cr
Previous quarter PATRs. 59.52 Cr
Previous quarter EBITDA margin26.9%
Market capRs. 10245.74 Cr
CMPRs. 1623.15

Manorama Industries Limited Q1 Results Date and Time

The board meeting is scheduled for August 13, 2026, to consider the unaudited standalone and consolidated financial results for Q1 FY27.

The earnings conference call is scheduled for August 14, 2026, at 1:30 PM IST.

What to expect from Manorama Industries Limited's Q1 FY27 results

Manorama enters Q1 FY27 with a strong base, supported by a 52,000 MTPA fractionation capacity and a 9% YoY weakening of the rupee, which provides a translation tailwind for its 57% export-oriented revenue. The company's cost-plus manufacturing model for top-tier MNC clients, combined with the recent halving of basic customs duty on crude palm oil to 10% effective March 24, 2026, should provide structural support to margins. While startup losses from nine new global subsidiaries and potential byproduct price volatility remain factors, the company's large inventory buffer of Rs. 727.78 Cr as of March 31, 2026, acts as a hedge against near-term raw material price fluctuations. Management's guidance for FY27 revenue growth of 30% or more and sustainable EBITDA margins of 25-27% will be the key benchmarks for this quarter's performance. The upcoming call will likely focus on the run-rate of revenue growth, the impact of the customs inquiry deposit on the P&L, and the deployment strategy for the Rs. 500 Cr QIP proceeds.

Key Things To Watch

Performance vs Guidance Tracking: Tracking progress against management's stated FY27 and long-term targets.

  • Revenue growth on and above 30% — FY27 — Q1 run-rate check
  • EBITDA margin 25-27% — Yearly — Q1 margin sustainability check
  • Capex Rs. 460 Cr — Over next 2-3 years — Update on phasing and project status

Customs Duty Inquiry: Monitoring the regulatory inquiry regarding India-UAE CEPA preferential tariff claims.

  • Status of the inquiry and any potential show-cause notices issued post-deposit
  • Recovery progress of the Rs. 20.64 Cr deposit from the UAE supplier
  • Impact of the inquiry on future India-UAE CEPA tariff claims

Strategic Expansion and QIP Deployment: Evaluating the execution of the company's growth strategy following the recent capital raise.

  • Utilization plan for Rs. 500 Cr QIP proceeds across working capital and capex
  • Construction and operational timeline for the Burkina Faso processing facility
  • Progress update on the newly incorporated Chad subsidiary and Brazil operations

Operating Metric Trajectory: Key performance indicators reflecting operational efficiency.

  • Capacity utilization levels following the completion of SF2 debottlenecking
  • CBE contribution to total revenue as it trends toward long-term targets
  • Trajectory of startup losses from African subsidiaries compared to FY26 levels

Frequently Asked Questions

How did Manorama's revenue perform in the previous quarter?

Manorama reported standalone revenue of Rs. 382.30 Cr in Q4 FY26, representing a sequential growth of 5.3% compared to Rs. 363 Cr in Q3 FY26.

What is the status of the customs inquiry mentioned in the recent disclosures?

The company received a summons under Section 108 of the Customs Act regarding India-UAE CEPA tariff claims and voluntarily deposited Rs. 20.64 Cr on July 29, 2026. Manorama has issued a debit note to the UAE supplier for reimbursement and reserved its rights to arbitration.

What is the company's current guidance for revenue growth and EBITDA margins?

Management has provided guidance for FY27 revenue growth of 30% or more and a sustainable EBITDA margin range of 25-27% on a yearly basis. These targets are supported by capacity expansion and an improved value-added product mix.

Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings

Login Now